Alpha 2.0
Login Register
» Authors » Ivana Koborova

Ivana Koborova

Explore the profile of Ivana Koborova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 89
Followers 0
Related Specialties
General Medicine
Biochemistry
Public Health
Top 10 Co-Authors
Katarina Sebekova
Radana Gurecka
Melinda Csongova
Peter Celec
Jozef Sebek
Eva Szoko
Tamas Tabi
Katarina Volkovova
Katarina Jansakova
Veronika Somoza
Published In
Vnitr Lek
Int J Environ Res Public Health
Croat Med J
Steroids
PLoS One
Affiliations
Soon will be listed here.
Recent Articles
1.
Association of Atherogenic Index of Plasma with Cardiometabolic Risk Factors and Markers in Lean 14-to-20-Year-Old Individuals: A Cross-Sectional Study
Sebekova K, Gurecka R, Csongova M, Koborova I, Celec P
Children (Basel) . 2023 Jul; 10(7). PMID: 37508640
Cardiometabolic risk factors at a young age pose a significant risk for developing atherosclerotic cardiovascular disease in adulthood. Atherogenic dyslipidemia is highly associated with obesity and metabolic syndrome already in...
2.
Association of Inflammatory and Oxidative Status Markers with Metabolic Syndrome and Its Components in 40-to-45-Year-Old Females: A Cross-Sectional Study
Sebekova K, Staruchova M, Mislanova C, Liskova A, Horvathova M, Tulinska J, et al.
Antioxidants (Basel) . 2023 Jun; 12(6). PMID: 37371951
Oxidative stress and sterile inflammation play roles in the induction and maintenance of metabolic syndrome (MetS). This study cohort included 170 females aged 40 to 45 years who were categorized...
3.
Association of α-Dicarbonyls and Advanced Glycation End Products with Insulin Resistance in Non-Diabetic Young Subjects: A Case-Control Study
Csongova M, Scheijen J, van de Waarenburg M, Gurecka R, Koborova I, Tabi T, et al.
Nutrients . 2022 Nov; 14(22). PMID: 36432614
α-Dicarbonyls and advanced glycation end products (AGEs) may contribute to the pathogenesis of insulin resistance by a variety of mechanisms. To investigate whether young insulin-resistant subjects present markers of increased...
4.
The Presence of Hyperhomocysteinemia Does Not Aggravate the Cardiometabolic Risk Imposed by Hyperuricemia in Young Individuals: A Retrospective Analysis of a Cross-Sectional Study
Sebekova K, Gurecka R, Repiska G, Koborova I, Podracka L
Int J Environ Res Public Health . 2022 Oct; 19(20). PMID: 36294101
Background: Little research has been conducted into the effects of the combined manifestation of hyperuricemia and hyperhomocysteinemia on cardiometabolic risk factors and markers in young subjects. Methods: 1298 males and...
5.
Lean insulin-resistant young adults display increased cardiometabolic risk: A retrospective cross-sectional study
Sebekova K, Gurecka R, Csongova M, Koborova I, Repiska G, Podracka L
Diabetes Res Clin Pract . 2022 Feb; 185:109217. PMID: 35114297
Aim: We investigated whether lean insulin-resistant individuals manifest increased cardiometabolic risk. Methods: 2,341 (51.8% females) healthy 16-23-year-old subjects were categorized as lean or overweight/obese; and insulin-sensitive or insulin-resistant, and compared....
6.
Circulating extracellular DNA is in association with continuous metabolic syndrome score in healthy adolescents
Celec P, Janovicova L, Gurecka R, Koborova I, Gardlik R, Sebekova K
Physiol Genomics . 2021 Jun; 53(7):309-318. PMID: 34097532
Obesity is associated with chronic low-grade inflammation that eventually leads to metabolic complications. Extracellular DNA (ecDNA) is a damage-associated molecular pattern. Extracellular mitochondrial DNA can activate innate immunity. We hypothesized...
7.
Sex Differences in Association of Elevated Blood Pressure with Variables Characterizing Cardiometabolic Risk in Young Subjects with or Without Metabolic Abnormalities
Sebekova K, Gurecka R, Csongova M, Koborova I, Sebek J
Int J Environ Res Public Health . 2020 May; 17(10). PMID: 32455627
Males present higher blood pressure (BP) values, higher prevalence of elevated BP, and a different prevalence of cardiometabolic risk factors when compared with females. We assumed that the trends of...
8.
Elevated blood pressure-associated cardiometabolic risk factors and biomarkers in 16-23 years old students with or without metabolic abnormalities
Sebekova K, Gurecka R, Csongova M, Koborova I, Sebek J
J Hum Hypertens . 2020 Feb; 35(1):37-48. PMID: 32029913
In obesity, cardiometabolic risk markers show worsening trends with increasing blood pressure (BP). We assumed that risk markers show similar trends across BP categories (normotension, high normal BP, hypertension) in...
9.
Estimation of the proportion of metabolic syndrome-free subjects on high cardiometabolic risk using two continuous cardiometabolic risk scores: a cross-sectional study in 16- to 20-year-old individuals
Sebekova K, Gurecka R, Csongova M, Koborova I, Sebek J
Eur J Pediatr . 2019 Jun; 178(8):1243-1253. PMID: 31203446
In contrast to the dichotomous classification of metabolic syndrome, continuous metabolic syndrome scores enable to assess cardiometabolic burden in metabolic syndrome-free individuals. Using receiver operating characteristics analysis, discrimination power of...
10.
Gender-associated differences in the prevalence of central obesity using waist circumference and waist-to-height ratio, and that of general obesity, in Slovak adults
Csongova M, Volkovova K, Gajdos M, Gurecka R, Koborova I, Liskova A, et al.
Cent Eur J Public Health . 2018 Nov; 26(3):228-233. PMID: 30419627
Objectives: Central obesity represents an increased risk to develop cardiovascular diseases. Guidelines of international societies suggest estimating central obesity by measuring waist circumference (WC). Robust statistical data in literature provide...